ZFIN ID: ZDB-FISH-150901-3952
Fish name: mi4Tg
Genotype: mi4Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by mi4Tg
No data available
GENE EXPRESSION
Gene expression in mi4Tg
RNA expression
Expressed Gene Structure Conditions Figures
alcama physical alteration: anatomical structure Fig. 6 from Fausett et al., 2006
ascl1a standard conditions Fig. 4 from Fausett et al., 2008
chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: eye Fig. 1Fig. 2 from Ramachandran et al., 2012
Fig. 1 with imageFig. 4 with image from Ramachandran et al., 2011
Fig. 4 from Fausett et al., 2008
dkk1a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk1b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk2 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk3a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
dkk3b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd2 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1 with imageFig. 2 with imageFig. 4 with image from Ramachandran et al., 2011
fzd3a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd8a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd8b physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
fzd9a physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
gapdh physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
gli3 perforation: retina Fig. 1 with image from Kaur et al., 2018
igf1ra perforation: retina Fig. 2 with image from Wan et al., 2014
igf1rb perforation: retina Fig. 2 with image from Wan et al., 2014
igfbp3 perforation: retina Fig. 2 with image from Wan et al., 2014
insm1a mechanical stress Fig. 1Fig. 2 from Ramachandran et al., 2012
insra perforation: retina Fig. 1 with image from Wan et al., 2014
insrb perforation: retina Fig. 1 with image from Wan et al., 2014
lin28a chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 4 with image from Ramachandran et al., 2011
Fig. 1 from Ramachandran et al., 2010
myca chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 4 with image from Ramachandran et al., 2011
pax6a standard conditions Fig. 7 from Fausett et al., 2008
Fig. 4 from Fausett et al., 2006
chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 4 with image from Ramachandran et al., 2011
Fig. 4 from Fausett et al., 2006
ptch1 perforation: retina Fig. 1 with image from Kaur et al., 2018
shha perforation: retina Fig. 1 with image from Kaur et al., 2018
smo perforation: retina Fig. 1 with image from Kaur et al., 2018
tuba1b physical alteration: eye Fig. 7 from Fausett et al., 2008
wnt2 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt2ba physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt3 physical alteration: anatomical structure Fig. 1 with image from Ramachandran et al., 2011
wnt4 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1 with imageFig. 2 with imageFig. 4 with image from Ramachandran et al., 2011
wnt8b physical alteration: anatomical structure Fig. 1 with imageFig. 2 with image from Ramachandran et al., 2011
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab2-ctnnb control Fig. 3 with image from Ramachandran et al., 2011
zpr-1 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
Ab2-ctnnb chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
Ab1-shha perforation: retina Fig. 1 with image from Kaur et al., 2018
Ab1-elavl chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
Ab1-glul chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
zn-5 chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
Ab1-glul perforation: retina Fig. 1 from Ramachandran et al., 2010
Ab1-insm1a mechanical stress Fig. 1 from Ramachandran et al., 2012
Ab2-ctnnb physical alteration: anatomical structure Fig. 3 with image from Ramachandran et al., 2011
Reporter gene expression
Expressed Gene Structure Conditions Figures
EGFP standard conditions Fig. 6Fig. 7Fig. S1 from Fausett et al., 2008
physical alteration: eye Fig. 1 from Fausett et al., 2008
GFP control Fig. 3 with image from Ramachandran et al., 2011
Fig. 2 from Ramachandran et al., 2010
chemical treatment: pharmaceutical Fig. 4 with image from Ramachandran et al., 2011
physical alteration: anatomical structure Fig. 1 with image from Kaur et al., 2018
Fig. 7 with imageFig. 8 with image from Rajaram et al., 2014
Fig. 2 with image from Powell et al., 2013
Fig. 5 from Powell et al., 2012
Fig. 1 from Ramachandran et al., 2012
Fig. 3 with image from Ramachandran et al., 2011
Fig. 1 from Ramachandran et al., 2010
PHENOTYPE
Phenotype in mi4Tg
Phenotype Conditions Figures
Muller cell cell dedifferentiation decreased occurrence, abnormal perforation: retina, chemical treatment: Cyclopamine Fig. 1 with image from Kaur et al., 2018
regenerating tissue Muller cell decreased amount, abnormal perforation: retina, chemical treatment: Cyclopamine Fig. 1 with image from Kaur et al., 2018
retina regeneration process quality, abnormal physical alteration: anatomical structure, chemical treatment: pharmaceutical Fig. 2 with image from Powell et al., 2013

CITATIONS  (16)